In vitro characterization of the effectiveness of enhanced sewage treatment processes to eliminate endocrine activity of hospital effluents

Water Research

Volumn 47, Issue 4, 2013, Pages 1545-1557

  Maletz, Sibylle ^a   Floehr, Tilman ^a   Beier, Silvio ^a,h   Klümper, Claudia ^a,i   Brouwer, Abraham ^b   Behnisch, Peter ^b   Higley, Eric ^c   Giesy, John P ^c,d,e,f   Hecker, Markus ^c,g   Gebhardt, Wilhelm ^a   Linnemann, Volker ^a   Pinnekamp, Johannes ^a   Hollert, Henner ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b BIODETECTION SYSTEMS B V   (Netherlands)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e NANJING UNIVERSITY   (China)

^f MICHIGAN STATE UNIVERSITY   (United States)

^g University of Saskatchewan   (Canada)

^h HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

ⁱ IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

Estrogenic action; Europe; H295R; LYES; Membrane bioreactor; Ozonation

Indexed keywords

AQUATIC ECOSYSTEMS; BIOREACTORS; CHEMICAL ANALYSIS; DRUG PRODUCTS; EFFICIENCY; EFFLUENTS; GENE EXPRESSION; HOSPITALS; METABOLITES; OZONE; OZONE WATER TREATMENT; OZONIZATION; SEWAGE TREATMENT; SODIUM HYDROXIDE; WOOD;

ACTIVE METABOLITES; ESTROGENIC ACTION; EUROPE; H295R; MEMBRANE BIO REACTOR (MBR); MEMBRANE BIOREACTOR; SEWAGE TREATMENT PROCESS; YEAST ESTROGEN SCREEN;

WASTEWATER TREATMENT;

AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; INDUSTRIAL EFFLUENT;

BIOREACTOR; DRUG; EFFLUENT; ENDOCRINE DISRUPTOR; ESTROGENIC COMPOUND; GENE EXPRESSION; HOSPITAL SECTOR; METABOLITE; MONITORING; OZONE; POLLUTANT REMOVAL; RISK ASSESSMENT; SEWAGE TREATMENT; STEROID;

ARTICLE; BIOASSAY; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); ENDOCRINE FUNCTION; ENZYME ACTIVITY; ENZYME MEMBRANE BIOREACTOR; ESTROGEN RECEPTOR MEDIATED CHEMICAL ACTIVATED LUCIFERASE GENE EXPRESSION; GERMANY; IN VITRO STUDY; LYTICASE YEAST ESTROGEN SCREEN; OZONATION; PRIORITY JOURNAL; SEWAGE TREATMENT; STEROIDOGENESIS; TRANSACTIVATION;

GERMANY;

EID: 84873523288     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2012.12.008     Document Type: Article

References (74)

1. BDS Analysis of Estrogen Receptor Mediated Luciferase Activity in ER CALUX Cells 2007, P-BDS-011(H).
2. Beck I.-C., Bruhn R., Gandrass J. Analysis of estrogenic activity in coastal surface waters of the Baltic Sea using the yeast estrogen screen. Chemosphere 2006, 63(11):1870-1878.
3. Bogers R., De Vries-Buitenweg S., Geuijen I., van de Waart B., Kuiper R., Van Der Linden S., Puijker L., Murk A., Van Der Burg B., Legler J. An in vitro/in vivo screening assay as a sensitive tool to assess endocrine disruptive activity in surface water. Environment International 2007, 33(3):292-301.
4. Bratkowska D., Fontanals N., Borrull F., Cormack P.A.G., Sherrington D.C., Marcé R.M. Hydrophilic hypercrosslinked polymeric sorbents for the solid-phase extraction of polar contaminants from water. Journal of Chromatography A 2010, 1217(19):3238-3243.
5. Cahill J.D., Furlong E.T., Burkhardt M.R., Kolpin D., Anderson L.G. Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. Journal of Chromatography A 2004, 1041(1-2):171-180.
6. Caldwell D.J., Mastrocco F., Hutchinson T.H., Lange R., Heijerick D., Janssen C., Anderson P.D., Sumpter J.P. Derivation of an aquatic predicted no-effect concentration for the synthetic hormone, 17 alpha-ethinyl estradiol. Environmental Science & Technology 2008, 42(19):7046-7054.
7. Caliman F.A., Gavrilescu M. Pharmaceuticals, personal care products and endocrine disrupting agents in the environment - a review. Clean-soil Air Water 2009, 37(4-5):277-303.
8. Chapman S., Leslie G., Law I.B. Membrane bioreactors (MBR) for municipal wastewater treatment - an Australian perspective. Journal of Australian Water Association 2004, 65(4).
9. Coleman H.M., Troester M., Khan S.J., McDonald J.A., Watkins G., Stuetz R.M. Assessment of trace organic chemical removal by a membrane bioreactor using gas chromatography/mass spectrometry and a yeast screen bioassay. Environmental Toxicology and Chemistry 2009, 28(12):2537-2545.
10. Connolly L., Ropstad E., Verhaegen S. In vitro bioassays for the study of endocrine-disrupting food additives and contaminants. TrAC Trends in Analytical Chemistry 2011, 30(2):227-238.
11. Cooper E.R., Siewicki T.C., Phillips K. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Science of the Total Environment 2008, 398(1-3):26-33.
12. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environmental Health Perspectives 1999, 107:907-938.
13. Dudley M.W., Sheeler C.Q., Wang H., Khan S. Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: implications for their mechanism of action. Proceedings of the National Academy of Sciences 2000, 97(7):3696-3701.
14. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Research 2011, 45(1):75-92.
15. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquatic Toxicology 2006, 76(2):122-159.
16. Fick J., Lindberg R.H., Tysklind M., Larsson D.G.J. Predicted critical environmental concentrations for 500 pharmaceuticals. Regulatory Toxicology and Pharmacology 2010, 58(3):516-523.
17. Gebhardt W., Schröder H.F. Liquid chromatography-(tandem) mass spectrometry for the follow-up of the elimination of persistent pharmaceuticals during wastewater treatment applying biological wastewater treatment and advanced oxidation. Journal of Chromatography. A 2007, 1160(1-2):34-43.
18. Gracia T., Jones P.D., Higley E.B., Hilscherova K., Newsted J.L., Murphy M.B., Chan A.K.Y., Zhang X.W., Hecker M., Lam P.K.S., Wu R.S.S., Giesy J.P. Modulation of steroidogenesis by coastal waters and sewage effluents of Hong Kong, China, using the H295R assay. Environmental Science and Pollution Research 2008, 15(4):332-343.
19. Grund S., Higley E., Schoenenberger R., Suter M.J.F., Giesy J.P., Braunbeck T., Hecker M., Hollert H. The endocrine disrupting potential of sediments from the Upper Danube River (Germany) as revealed by in vitro bioassays and chemical analysis. Environmental Science and Pollution Research International 2011, 18(3):446-460.
20. Gunnarsson L., Adolfsson-Erici M., Bjorlenius B., Rutgersson C., Forlin L., Larsson D.G.J. Comparison of six different sewage treatment processes-reduction of estrogenic substances and effects on gene expression in exposed male fish. Science of the Total Environment 2009, 407(19):5235-5242.
21. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicology Letters 2002, 131(1-2):5-17.
22. Hecker M., Hollert H. Effect-directed analysis (EDA) in aquatic ecotoxicology: state of the art and future challenges. Environmental Science and Pollution Research 2009, 16(6):607-613.
23. Hecker M., Hollert H. Endocrine disruptor screening: regulatory perspectives and needs. Environmental Sciences Europe 2011, 23(1):1-14.
24. Hecker M., Hollert H., Cooper R., Vinggaard A.M., Akahori Y., Murphy M., Nellemann C., Higley E., Newsted J., Laskey J., Buckalew A., Grund S., Maletz S., Giesy J., Timm G. The OECD validation program of the H295R steroidogenesis assay: phase 3. Final inter-laboratory validation study. Environmental Science and Pollution Research International 2011, 18(3):503-515.
25. Hecker M., Hollert H., Cooper R., Vinggaard A.M., Akahori Y., Murphy M., Nellemann C., Higley E., Newsted J., Wu R., Lam P., Laskey J., Buckalew A., Grund S., Nakai M., Timm G., Giesy J. The OECD validation program of the H295R steroidogenesis assay for the identification of in vitro inhibitors and inducers of testosterone and estradiol production. Phase 2: inter-laboratory pre-validation studies. Environmental Science and Pollution Research 2007, 14(1):23-30.
26. Higley E.B., Newsted J.L., Zhang X., Giesy J.P., Hecker M. Assessment of chemical effects on aromatase activity using the H295R cell line. Environmental Science and Pollution Research International 2010, 17(5):1137-1148.
27. Holbrook R.D., Novak J.T., Grizzard T.J., Love N.G. Estrogen receptor agonist fate during wastewater and biosolids treatment processes: a mass balance analysis. Environmental Science & Technology 2002, 36(21):4533-4539.
28. Hollert H., Durr M., Holtey-Weber R., Islinger M., Brack W., Farber H., Erdinger L., Braunbeck T. Endocrine disruption of water and sediment extracts in. a non-radioactive dot blot/RNAse protection-assay using isolated hepatocytes of rainbow trout - deficiencies between bioanalytical effectiveness and chemically determined concentrations and how to explain them. Environmental Science and Pollution Research 2005, 12(6):347-360.
29. Howdeshell K.L., Peterman P.H., Judy B.M., Taylor J.A., Orazio C.E., Ruhlen R.L., vom Saal F.S., Welshons W.V. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environmental Health Perspectives 2003, 111(9):1180-1187.
30. Hu J.Y., Chen X., Tao G., Kekred K. Fate of endocrine disrupting compounds in membrane bioreactor systems. Environmental Science & Technology 2007, 41(11):4097-4102.
31. Huber M.M., Göbel A., Joss A., Hermann N., Löffler D., McArdell C.S., Ried A., Siegrist H., Ternes T.A., von Gunten U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environmental Science & Technology 2005, 39(11):4290-4299.
32. Huber M.M., Ternes T.A., von Gunten U. Removal of estrogenic activity and formation of oxidation products during ozonation of 17 alpha-ethinylestradiol. Environmental Science & Technology 2004, 38(19):5177-5186.
33. Ji K., Choi K., Lee S., Park S., Khim J.S., Jo E.-H., Choi K., Zhang X., Giesy J.P. Effects of sulfathiazole, oxytetracycline and chlortetracycline on steroidogenesis in the human adrenocarcinoma (H295R) cell line and freshwater fish Oryzias latipes. Journal of Hazardous Materials 2010, 182(1-3):494-502.
34. Kase R., Kunz P., Gerhardt A. Identifikation geeigneter Nachweismöglichkeiten von hormonaktiven und reproduktionstoxischen Wirkungen in aquatischen ökosystemen. Umweltwissenschaften und Schadstoff-Forschung 2009, 21(4):339-378.
35. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Research 2009, 43(2):363-380.
36. Kunz P.Y., Galicia H.F., Fent K. Comparison of in vitro and in vivo estrogenic activity of UV filters in fish. Toxicological Sciences 2006, 90(2):349-361.
37. Lamoree M.H., Derksen J.G.M., van der Linden S.C., Uijterlinde C.A., de Voogt P. Efficiency of Removal of Compounds with Estrogenic Activity During Wastewater Treatment: Effects of Various Removal Techniques 2010.
38. Laven M., Alsberg T., Yu Y., Adolfsson-Erici M., Sun H.W. Serial mixed-mode cation- and anion-exchange solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Journal of Chromatography A 2009, 1216(1):49-62.
39. Legler J., Dennekamp M., Vethaak A.D., Brouwer A., Koeman J.H., van der Burg B., Murk A.J. Detection of estrogenic activity in sediment-associated compounds using in vitro reporter gene assays. Science of the Total Environment 2002, 293(1-3):69-83.
40. Legler J., van den Brink C.E., Brouwer A., Murk A.J., van der Saag P.T., Vethaak A.D., van der Burg P. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicological Sciences 1999, 48(1):55-66.
41. Legler J., Zeinstra L., Schuitemaker F., Lanser P., Bogerd J., Brouwer A., Vethaak A., De Voogt P., Murk A., Van der Burg B. Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environmental Science & Technology 2002, 36(20):4410-4415.
42. Lephart E.D., Simpson E.R. Assay of Aromatase-activity. Methods in Enzymology 1991, 206:477-483.
43. Leusch F.D.L. Tools to Detect Estrogenic Activity in Environmental Waters 2008, Global Water Research Coalition.
44. Leusch F.D.L., De Jager C., Levi Y., Lim R., Puijker L., Sacher F., Tremblay L.A., Wilson V.S., Chapman H.F. Comparison of five in vitro bioassays to measure estrogenic activity in environmental waters. Environmental Science & Technology 2010, 44(10):3853-3860.
45. Moltmann J.F., Liebig M., Knacker T., Keller M., Scheurer M., Ternes T. Relevance of Ondocrine Disrupting Substances and Pharmaceuticals in Surface Waters 2007, 1-129. Umweltbundesamt. Ect, BfG (Eds.).
46. Murk A.J., Legler J., van Lipzig M.M.H., Meerman J.H.N., Belfroid A.C., Spenkelink A., van der Burg B., Rijs G.B.J., Vethaak D. Detection of estrogenic potency in wastewater and surface water with three in vitro bioassays. Environmental Toxicology and Chemistry 2002, 21(1):16-23.
47. Ort C., Lawrence M.G., Reungoat J., Eaglesham G., Carter S., Keller J. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Research 2010, 44(2):605-615.
48. Petala M., Samaras P., Zouboulis A., Kungolos A., Sakellaropoulos G.P. Influence of ozonation on the in vitro mutagenic and toxic potential of secondary effluents. Water Research 2008, 42(20):4929-4940.
49. Petit F., Le Goff P., Cravedi J., Valotaire Y., Pakdel F. Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyte cultures. Journal of Molecular Endocrinology 1997, 19(3):321-335.
50. Pinnekamp J., Beier S., Cramer C., Schröder H.F., Mauer C., Selke D. Eliminierung von Spurenstoffen aus Krankenhausabwässern mit Membrantechnik und weitergehenden Behandlungsverfahren - Pilotprojekt Kreiskrankenhaus Waldbröl 2009, Abschlussbericht im Auftrag des Ministeriums für Umwelt und Naturschutz, Landwirtschaft und Verbraucherschutz des Landes Nordrhein- Westfalen, Förderkennzeichen IV - 9 - 042 1B4 0020.
51. Rosal R., Rodríguez A., Perdigón-Melón J.A., Petre A., García-Calvo E., Gómez M.J., Agüera A., Fernández-Alba A.R. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Research 2010, 44(2):578-588.
52. Routledge E.J., Sumpter J.P. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environmental Toxicology and Chemistry 1996, 15(3):241-248.
53. Sanderson J.T., Letcher R.J., Heneweer M., Giesy J.P., van den Berg M. Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. Environmental Health Perspectives 2001, 109(10):1027-1031.
54. Schultis T., Metzger J.W. Determination of estrogenic activity by LYES-assay (yeast estrogen screen-assay assisted by enzymatic digestion with lyticase). Chemosphere 2004, 57(11):1649-1655.
55. Sim W.-J., Lee J.-W., Shin S.-K., Song K.-B., Oh J.-E. Assessment of fates of estrogens in wastewater and sludge from various types of wastewater treatment plants. Chemosphere 2011, 82(10):1448-1453.
56. Sonneveld E., Riteco J.A.C., Jansen H.J., Pieterse B., Brouwer A., Schoonen W.G., van der Burg B. Comparison of invitro and in vivo screening models for androgenic and estrogenic activities. Toxicological Sciences 2006, 89(1):173-187.
57. Stalter D., Magdeburg A., Oehlmann J. Comparative toxicity assessment of ozone and activated carbon treated sewage effluents using an in vivo test battery. Water Research 2010, 44(8):2610-2620.
58. Stalter D., Magdeburg A., Weil M., Knacker T., Oehlmann J. Toxication or detoxication? in vivo toxicity assessment of ozonation as advanced wastewater treatment with the rainbow trout. Water Research 2010, 44(2):439-448.
59. Stalter D., Magdeburg A., Wagner M., Oehlmann J. Ozonation and activated carbon treatment of sewage effluents: removal of endocrine activity and cytotoxicity. Water Research 2011, 45(3):1015-1024.
60. Ternes T.A., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science & Technology 2004, 38(20):392a-399a.
61. Ternes T.A., Stüber J., Herrmann N., McDowell D., Ried A., Kampmann M., Teiser B. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water Research 2003, 37(8):1976-1982.
62. Ternes T.A., Stumpf M., Mueller J., Haberer K., Wilken R.D., Servos M. Behavior and occurrence of estrogens in municipal sewage treatment plants - I. Investigations in Germany, Canada and Brazil (vol. 225, pg 81, 1999). Science of the Total Environment 1999, 228(1):87.
63. Van der Linden S.C., Heringa M.B., Man H.-Y., Sonneveld E., Puijker L.M., Brouwer A., Van der Burg B. Detection of multiple hormonal activities in wastewater effluents and surface water, using a panel of steroid receptor CALUX bioassays. Environmental Science & Technology 2008, 42(15):5814-5820.
64. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. Journal of Hydrology 2010, 389(3-4):416-428.
65. Villeneuve D.L., Ankley G.T., Makynen E.A., Blake L.S., Greene K.J., Higley E.B., Newsted J.L., Giesy J.P., Hecker M. Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. Ecotoxicology and Environmental Safety 2007, 68(1):20-32.
66. von Gunten U. Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Research 2003, 37(7):1443-1467.
67. Wagner M., Oehlmann J. Endocrine disruptors in bottled mineral water: total estrogenic burden and migration from plastic bottles. Environmental Science and Pollution Research 2009, 16(3):278-286.
68. Watanabe M., Nakajin S. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R. Journal of Endocrinology 2004, 180(1):125-133.
69. Westerhoff P., Yoon Y., Snyder S., Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environmental Science & Technology 2005, 39(17):6649-6663.
70. Ying G.-G., Kookana R.S., Ru Y.-J. Occurrence and fate of hormone steroids in the environment. Environment International 2002, 28(6):545-551.
71. Zwiener C., Frimmel F.H. Oxidative treatment of pharmaceuticals in water. Water Research 2000, 34(6):1881-1885.
72. Zwiener C., Frimmel F.H. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Science of the Total Environment 2003, 309(1-3):201-211.
73. Zwiener C., Gremm T.J., Frimmel F.H. Pharmaceutical residues in the aquatic environment and their significance for drinking water production. Pharmaceuticals in the Environment 2001, 81-89.
74. Zwiener C., Seeger S., Glauner T., Frimmel F.H. Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Analytical and Bioanalytical Chemistry 2002, 372(4):569-575.